Alnair Therapeutics

👥 3 employees💰 Last funded 2023
Biotechnology Research
LinkedIn
Alnair is a preclinical stage, platform precision oncology company focused on new methods to treat difficult-to-treat cancers. We developed a first-in-class drug delivery technology that leverages the unique features of cancer metabolism to enhance targeting and penetration of drugs directly to cancer cells, and to improve treatment outcomes for patients.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Alnair Therapeutics?
Alnair Therapeutics has 1 investors on record on gritt.io.
When did Alnair Therapeutics last raise funding?
The most recent investment in Alnair Therapeutics recorded on gritt.io was in 2023.
What industry is Alnair Therapeutics in?
Alnair Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.